AusPAR: Ivermectin

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

4 January 2016
AusPAR Details
AusPAR
AusPAR: Ivermectin (pdf, 809 KB)
AusPAR: Ivermectin (docx, 624 KB)
Attachment: Product Information 1: Ivermectin (pdf, 324 KB)
Attachment: Product Information 1: Ivermectin (docx, 258 KB)
Attachment: Product Information 2: Ivermectin (pdf, 347 KB)
Attachment: Product Information 2: Ivermectin (docx, 256 KB)
Attachment: Extract from the Clinical Evaluation Report: Ivermectin (pdf, 2 MB)
Attachment: Extract from the Clinical Evaluation Report: Ivermectin (docx, 3 MB)
Active Ingredient
Ivermectin
Product Name
Vastreka / Soolantra
Sponsor
Galderma Australia Pty Ltd
Submission Number
PM-2014-01877-1-2
Submission Type
Major variation (new dose form, new indications)
Decision
Approved
AusPAR Date
9 December 2015
Publication Date

4 January 2016
Category: 
Prescription medicines
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/712702